Ben-Ajepe Temitope, Nwogu Ifechukwu Benedict, Olaoye Damilola Quazeem, Mustapha Abdulhafeez Ayodele, Uwizeyimana Theogene, Adebisi Yusuff Adebayo
Dora Akunyili College of Pharmacy, Igbinedion University, Okada, Edo, Nigeria.
Advantage Health Africa, Lagos, Nigeria.
J Pharm Policy Pract. 2021 May 31;14(1):47. doi: 10.1186/s40545-021-00328-5.
Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in demands for healthcare, which unfortunately have been met with inequitable distribution of drugs. Hence, the outcomes from healthcare interventions are frequently not maximized. These problems notably call for some economic principles and policies to guide medication selection, procurement, or donation for population prioritization or health insurance. Pharmacoeconomics drives efficient use of scarce or limited resources to maximize healthcare benefits and reduce costs. It also brings to play tools that rate therapy choice based on the quality of life added to the patient after a choice of intervention was made over an alternative. In this paper, we commented on the needs, prospect, and challenges of pharmacoeconomics in Africa.
随着需求的增加,非洲大陆的医疗保健成本持续上升。由于许多非洲国家生活在贫困线以下,非洲人继续死于可预防和可治愈的疾病。人口增长导致医疗保健需求增加,但不幸的是,药品分配不均。因此,医疗干预的效果往往无法最大化。这些问题尤其需要一些经济原则和政策来指导药物选择、采购或捐赠,以实现人群优先排序或医疗保险。药物经济学推动有效利用稀缺或有限的资源,以最大化医疗保健效益并降低成本。它还运用一些工具,根据在选择一种干预措施而非另一种干预措施后给患者带来的生活质量来评估治疗选择。在本文中,我们评论了非洲药物经济学的需求、前景和挑战。